Editorial
Declining Incidence of Systolic Left Ventricular Dysfunction in Human Immunodeficiency Virus–Infected Individuals Treated With Highly Active Antiretroviral Therapy

https://doi.org/10.1016/j.amjcard.2016.01.008Get rights and content

Section snippets

Acknowledgment

The authors thank the Pediatric HIV/AIDS Cohort Study network for their logistical support of this work.

References (16)

  • S.D. Fisher et al.

    Mild dilated cardiomyopathy and increased left ventricular mass predict mortality: the prospective P2C2 HIV Multicenter Study

    Am Heart J

    (2005)
  • P.F. Currie et al.

    Heart muscle disease related to HIV infection: prognostic implications

    BMJ

    (1994)
  • K. Sliwa et al.

    Contribution of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic to de novo presentations of heart disease in the Heart of Soweto Study cohort

    Eur Heart J

    (2012)
  • S.E. Lipshultz et al.

    Cardiac effects in perinatally HIV-infected and HIV-exposed but uninfected children and adolescents: a view from the United States of America

    J Int AIDS Soc

    (2013)
  • S.E. Lipshultz et al.

    Left ventricular structure and function in children infected with human immunodeficiency virus: the prospective P2C2 HIV Multicenter Study

    Circulation

    (1998)
  • K. Patel et al.

    The impact of HAART on cardiomyopathy among children and adolescents perinatally infected with HIV-1

    AIDS

    (2012)
  • S.E. Lipshultz et al.

    HAART to heart: highly active antiretroviral therapy and the risk of cardiovascular disease in HIV-infected or exposed children and adults

    Expert Rev Anti Infect Ther

    (2012)
  • S.D. Fisher et al.

    Cardiovascular disease and therapeutic drug-related cardiovascular consequences in HIV-infected patients

    Am J Cardiovasc Drugs

    (2011)
There are more references available in the full text version of this article.

Cited by (0)

See page 1195 for disclosure information.

View full text